MedPath

Randomized controlled trials of additional ramelteon to alpha1-blockers for nocturia with sleep disorders.

Phase 3
Recruiting
Conditions
Benign prostatic hypertroplasia
Registration Number
JPRN-UMIN000006712
Lead Sponsor
Yokohama city university school of medicine department of urology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patient with drug allergy 2)Severe liver dysfunction 3)During administration of Fluvoxamine maleate 4)Acute urinary tract infection 5)Physician deems inappropriate

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
number of nocturia
Secondary Outcome Measures
NameTimeMethod
IPSS, OABSS, N-QOL, PSQI, Safety
© Copyright 2025. All Rights Reserved by MedPath